[HLIND] YoY Cumulative Quarter Result on 31-Dec-2018 [#2]

Stock
[HLIND] HONG LEONG INDUSTRIES BHD
Announcement Date
18-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2019
Quarter
31-Dec-2018 [#2]
Profit Trend
QoQ- 123.83%
YoY- -4.87%
Quarter Report
Latest QR
Upcoming QR
HLIND's Result
HLIND's Financial Summary
View:
Show?
Cumulative Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 1,054,062 1,423,339 1,524,128 1,375,761 1,261,737 1,127,279 1,061,998 -0.12%
PBT 138,548 249,487 236,282 235,098 235,049 182,420 163,077 -2.67%
Tax -37,819 -47,669 -48,864 -40,849 -36,026 -26,059 -25,651 6.67%
NP 100,729 201,818 187,418 194,249 199,023 156,361 137,426 -5.04%
-
NP to SH 74,435 150,961 141,451 156,785 164,804 133,433 119,075 -7.52%
-
Tax Rate 27.30% 19.11% 20.68% 17.38% 15.33% 14.29% 15.73% -
Total Cost 953,333 1,221,521 1,336,710 1,181,512 1,062,714 970,918 924,572 0.51%
-
Net Worth 1,920,861 1,800,566 1,720,681 1,566,550 1,374,095 1,401,257 1,279,878 6.99%
Dividend
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Div 53,444 53,419 53,378 47,090 46,422 46,297 40,092 4.90%
Div Payout % 71.80% 35.39% 37.74% 30.04% 28.17% 34.70% 33.67% -
Equity
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Net Worth 1,920,861 1,800,566 1,720,681 1,566,550 1,374,095 1,401,257 1,279,878 6.99%
NOSH 327,903 327,903 327,903 327,903 327,905 327,905 308,404 1.02%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 9.56% 14.18% 12.30% 14.12% 15.77% 13.87% 12.94% -
ROE 3.88% 8.38% 8.22% 10.01% 11.99% 9.52% 9.30% -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 335.28 452.95 485.40 438.23 407.69 365.23 344.35 -0.44%
EPS 23.68 48.04 45.05 49.96 53.21 43.26 38.61 -7.81%
DPS 17.00 17.00 17.00 15.00 15.00 15.00 13.00 4.56%
NAPS 6.11 5.73 5.48 4.99 4.44 4.54 4.15 6.65%
Adjusted Per Share Value based on latest NOSH - 327,903
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 321.46 434.07 464.81 419.56 384.79 343.78 323.88 -0.12%
EPS 22.70 46.04 43.14 47.81 50.26 40.69 36.31 -7.52%
DPS 16.30 16.29 16.28 14.36 14.16 14.12 12.23 4.89%
NAPS 5.858 5.4912 5.2475 4.7775 4.1906 4.2734 3.9032 6.99%
Price Multiplier on Financial Quarter End Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 -
Price 9.18 8.89 10.42 8.50 9.69 9.40 5.93 -
P/RPS 2.74 1.96 2.15 1.94 2.38 2.57 1.72 8.06%
P/EPS 38.77 18.51 23.13 17.02 18.20 21.74 15.36 16.66%
EY 2.58 5.40 4.32 5.88 5.50 4.60 6.51 -14.28%
DY 1.85 1.91 1.63 1.76 1.55 1.60 2.19 -2.77%
P/NAPS 1.50 1.55 1.90 1.70 2.18 2.07 1.43 0.79%
Price Multiplier on Announcement Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 23/02/22 26/02/21 26/02/20 18/02/19 05/02/18 06/02/17 02/02/16 -
Price 9.70 8.18 9.40 9.42 9.50 9.76 5.62 -
P/RPS 2.89 1.81 1.94 2.15 2.33 2.67 1.63 10.00%
P/EPS 40.97 17.03 20.87 18.86 17.84 22.58 14.56 18.79%
EY 2.44 5.87 4.79 5.30 5.61 4.43 6.87 -15.83%
DY 1.75 2.08 1.81 1.59 1.58 1.54 2.31 -4.51%
P/NAPS 1.59 1.43 1.72 1.89 2.14 2.15 1.35 2.76%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment